Does SITAGLIPTIN Cause Stent placement? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Stent placement have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.3% of all adverse event reports for SITAGLIPTIN.
68
Reports of Stent placement with SITAGLIPTIN
0.3%
of all SITAGLIPTIN reports
48
Deaths
59
Hospitalizations
How Dangerous Is Stent placement From SITAGLIPTIN?
Of the 68 reports, 48 (70.6%) resulted in death, 59 (86.8%) required hospitalization, and 23 (33.8%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which SITAGLIPTIN Alternatives Have Lower Stent placement Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE